Eliquis 5 MG tablet 60S
Ended Awarded Last action
- Contract number
- SPE2DR26F7WXP
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,271
Award facts
- Contract value 100% obligated
- $10,271.20 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $10,271.20 to Amerisourcebergen Drug Corp (UEI: KABZK8W6PQT3) for the supply of Eliquis 5 mg tablets in quantities of 60 units. This firm fixed-price, competitively awarded contract was issued on January 28, 2026, with an ultimate completion date of January 29, 2026. The point of performance is located in Conshohocken, Pennsylvania, where Amerisourcebergen Drug Corp maintains its corporate headquarters. This delivery order is issued under Amerisourcebergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 31, 2031, which serves as the primary vehicle for supplying comprehensive pharmaceutical products and medical supplies to support military healthcare programs globally.
Amerisourcebergen Drug Corp operates as a critical federal vendor for pharmaceutical distribution and healthcare solutions, supplying brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. The company's extensive portfolio of federal contract awards with the Defense Logistics Agency demonstrates its capability to meet competitive procurement requirements for military and veteran healthcare systems. Eliquis, an anticoagulant medication, is a branded pharmaceutical product commonly used in federal healthcare programs. No set-aside designation was applied to this award, indicating it was competed on a full and open basis among eligible contractors.
Quick answers
Who was awarded contract SPE2DR26F7WXP?
SPE2DR26F7WXP was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 28, 2026.
How much is contract SPE2DR26F7WXP worth?
The government has obligated $10,271 on SPE2DR26F7WXP.
Is contract SPE2DR26F7WXP an order under another contract?
Yes. SPE2DR26F7WXP is a delivery order under SPE2DR25D7061, an indefinite delivery contract.
Was contract SPE2DR26F7WXP competed?
The extent of competition for SPE2DR26F7WXP was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award